Taxotere/ Docetaxel Winthrop er blevet undersøgt i en hovedundersøgelse med deltagelse af over 3. 000 kvinder med HER2- ekspressiv brystkræft, der kunne behandles kirurgisk.
Taxotere/ Docetaxel Winthrop has been studied in one main study involving over 3,000 women with HER2-expressing breast cancer that could be treated with surgery.